Correlation values with VAS score | Rho Spearman (ρ) | 95% confidence interval | |
---|---|---|---|
Q1 | 0.43 | 0.31 | 0.54 |
Q2 | 0.41 | 0.29 | 0.52 |
Q3 | 0.51 | 0.39 | 0.60 |
Q4 | 0.52 | 0.41 | 0.62 |
Q5 | 0.42 | 0.30 | 0.53 |
Q6 | 0.44 | 0.32 | 0.54 |
Q7 | 0.44 | 0.32 | 0.54 |
Q8 | 0.26 | 0.12 | 0.38 |
Q9 | 0.53 | 0.42 | 0.62 |
Q10 | 0.11 | -0.02 | 0.25 |
Q11 | 0.28 | 0.15 | 0.41 |
Symptom severity | 0.61 | 0.51 | 0.69 |
Impact on lifestyle and work | 0.48 | 0.36 | 0.58 |
Impact on health services | 0.24 | 0.10 | 0.36 |
Total | 0.68 | 0.59 | 0.74 |